Is USNA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for USNA. It does not provide personalized investment advice.

USNA (USANA Health Sciences Inc) Stock Analysis - Financials

USANA Health Sciences Inc (USNA) is a publicly traded Consumer Defensive sector company. As of September 1, 2026, USNA trades at $14.25 with a market cap of $259.41M and a P/E ratio of 6.41. USNA moved -0.07% today. Year to date, USNA is -27.36%; over the trailing twelve months it is -55.31%. Its 52-week range spans $12.57 to $38.32. Rallies surfaces USNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What are USNA's key financials?

USNA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. USNA recently traded at $14.25. Market cap is $259.41M. P/E ratio is 6.41. Revenue is $854.50M.

USNA Key Metrics

Key financial metrics for USNA
Metric	Value
Price	$14.25
Market Cap	$259.41M
P/E Ratio	6.41
EPS	$2.20
Dividend Yield	0.00%
52-Week High	$38.32
52-Week Low	$12.57
Volume	183
Avg Volume	0
Revenue (TTM)	$854.50M
Net Income	$42.06M
Gross Margin	81.13%

USNA Analyst Consensus

USNA analyst coverage data. Average price target: $0.00.

Common questions about USNA

What are USNA's key financials?: USNA financials on Rallies include revenue, net income, EPS, valuation metrics, market cap, price history, and balance sheet context. USNA recently traded at $14.25. Market cap is $259.41M. P/E ratio is 6.41. Revenue is $854.50M.
Is USNA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for USNA. It does not provide personalized investment advice.